BNP Paribas Financial Markets grew its holdings in shares of LiveRamp Holdings, Inc. (NYSE:RAMP - Free Report) by 71.3% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 161,848 shares of the company's stock after acquiring an additional 67,374 shares during the quarter. BNP Paribas Financial Markets owned about 0.25% of LiveRamp worth $4,011,000 at the end of the most recent quarter.
Other large investors have also recently modified their holdings of the company. Price T Rowe Associates Inc. MD raised its holdings in shares of LiveRamp by 8.6% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 22,755 shares of the company's stock valued at $786,000 after buying an additional 1,803 shares in the last quarter. DekaBank Deutsche Girozentrale bought a new stake in shares of LiveRamp in the 1st quarter worth approximately $87,000. Carolina Wealth Advisors LLC lifted its stake in LiveRamp by 11.2% in the second quarter. Carolina Wealth Advisors LLC now owns 27,349 shares of the company's stock worth $846,000 after purchasing an additional 2,764 shares during the last quarter. SG Americas Securities LLC bought a new position in shares of LiveRamp during the second quarter valued at about $509,000. Finally, Assenagon Asset Management S.A. increased its holdings in shares of LiveRamp by 32.0% in the second quarter. Assenagon Asset Management S.A. now owns 264,470 shares of the company's stock worth $8,183,000 after buying an additional 64,155 shares during the period. Institutional investors own 93.83% of the company's stock.
Analysts Set New Price Targets
Several equities analysts recently issued reports on the company. Craig Hallum reduced their price target on LiveRamp from $55.00 to $43.00 and set a "buy" rating on the stock in a research report on Thursday, August 8th. Macquarie restated an "outperform" rating and issued a $43.00 price objective on shares of LiveRamp in a research report on Thursday, November 7th. Wells Fargo & Company initiated coverage on LiveRamp in a report on Monday, October 28th. They issued an "equal weight" rating and a $25.00 price objective for the company. Benchmark dropped their price target on LiveRamp from $48.00 to $42.00 and set a "buy" rating for the company in a research note on Thursday, November 7th. Finally, Evercore ISI decreased their price objective on shares of LiveRamp from $50.00 to $40.00 and set an "outperform" rating for the company in a report on Thursday, August 8th. One analyst has rated the stock with a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $41.14.
Get Our Latest Report on RAMP
LiveRamp Stock Performance
Shares of LiveRamp stock traded down $0.76 on Thursday, hitting $30.91. 361,955 shares of the company's stock were exchanged, compared to its average volume of 642,267. The stock has a market capitalization of $2.02 billion, a PE ratio of 633.53 and a beta of 0.97. LiveRamp Holdings, Inc. has a 1 year low of $21.45 and a 1 year high of $42.66. The company has a 50-day simple moving average of $26.65 and a 200-day simple moving average of $27.90.
LiveRamp (NYSE:RAMP - Get Free Report) last released its quarterly earnings results on Wednesday, November 6th. The company reported $0.51 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.37 by $0.14. LiveRamp had a return on equity of 1.25% and a net margin of 0.40%. The business had revenue of $185.00 million during the quarter, compared to analyst estimates of $176.16 million. During the same quarter in the previous year, the company posted $0.21 earnings per share. LiveRamp's revenue for the quarter was up 15.6% on a year-over-year basis. On average, analysts expect that LiveRamp Holdings, Inc. will post 0.36 EPS for the current fiscal year.
Insider Activity at LiveRamp
In other news, insider Kimberly Bloomston sold 4,000 shares of the business's stock in a transaction on Thursday, September 26th. The shares were sold at an average price of $25.17, for a total value of $100,680.00. Following the transaction, the insider now owns 117,247 shares of the company's stock, valued at approximately $2,951,106.99. The trade was a 3.30 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Debora B. Tomlin sold 9,765 shares of LiveRamp stock in a transaction on Thursday, September 26th. The shares were sold at an average price of $25.07, for a total transaction of $244,808.55. Following the completion of the sale, the director now owns 24,509 shares in the company, valued at approximately $614,440.63. This represents a 28.49 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 3.39% of the stock is owned by corporate insiders.
LiveRamp Profile
(
Free Report)
LiveRamp Holdings, Inc, a technology company, operates a data collaboration platform in the United States, Europe, the Asia-Pacific, and internationally. The company operates LiveRamp Data Collaboration platform enables an organization to unify customer and prospect data to build a single view of the customer in a way that protects consumer privacy.
Featured Articles
Before you consider LiveRamp, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and LiveRamp wasn't on the list.
While LiveRamp currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.